Original Investigation |

Nasal Nitric Oxide Levels and Nasal Polyposis in Children and Adolescents With Cystic Fibrosis

Karin M. de Winter–de Groot, MD1; Sanne van Haren Noman, MD1; Lucienne Speleman, MD2; Anna G. M. Schilder, MD, PhD2,3; Cornelis K. van der Ent, MD, PhD1
[+] Author Affiliations
1Department of Paediatric Respiratory Medicine and Allergology, University Medical Center, Utrecht, the Netherlands
2Department of Otorhinolaryngology, University Medical Center, Utrecht, the Netherlands
3ENT Clinical Trials Programme, Ear Institute, Faculty of Brain Sciences, University College London, London, England
JAMA Otolaryngol Head Neck Surg. 2013;139(9):931-936. doi:10.1001/jamaoto.2013.4099.
Text Size: A A A
Published online

Importance  The counterintuitive decrease of exhaled nitric oxide (NO) levels in a severe inflammatory disorder like cystic fibrosis (CF) is only scarcely understood. Because NO is important in a variety of regulatory processes in the lung, including host defense, inflammation, and bronchomotor control, it is necessary to search for clarifying mechanisms.

Objectives  To explore whether fractional exhaled NO (FENO) and nasal NO (nNO) levels are associated with CF genotype, nutritional status, presence of nasal polyps, pulmonary function, and airway colonization with Staphylococcus aureus and Pseudomonas aeruginosa in children with CF, and to investigate the effect of functional endoscopic sinus surgery (FESS) on FENO and nNO levels in children with CF and persistent sinonasal disease.

Design, Setting, and Participants  Cross-sectional study (association with NO) and prospective study (effect of FESS on NO) in a tertiary care referral center. Patients included 95 children with CF in clinically stable condition at routine annual multidisciplinary examination, 13 of whom were referred for a FESS procedure.

Interventions  Functional endoscopic sinus surgery in children with CF and persistent sinonasal disease.

Main Outcomes and Measures  Body mass index (BMI), FENO and nNO levels, results of flexible nasal endoscopy, pulmonary function tests (forced expiratory volume in 1 second and forced vital capacity), and airway cultures.

Results  Children with nasal polyposis have significantly lower nNO levels than those without polyposis (median, 53 vs 140 parts per billion; P = .001); these values are negatively associated with colonization with S aureus (β = −.22; P = .04). After FESS, nNO values increase significantly, although not to normal levels.

Conclusions and Relevance  In children with CF, the presence of nasal polyps is associated with significantly lower nNO levels than in children without nasal polyps. After FESS for nasal polyposis, nNO levels increase significantly, but not to normal levels. Low nNO levels are associated with S aureus colonization in the oropharynx and lower airways.

Figures in this Article

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours


Place holder to copy figure label and caption
Figure 1.
Distribution of Mean Nasal Nitric Oxide (nNO) Levels in 95 Children With Cystic Fibrosis

Distribution of mean nNO levels in 95 children with cystic fibrosis. ppb indicates parts per billion.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.
Nasal Nitric Oxide (nNO) Levels Before and After Functional Endoscopic Sinus Surgery (FESS)

After FESS in 13 patients with cystic fibrosis and nasal polyposis, nNO levels increased significantly, although not to normal levels. ppb indicates parts per billion; Pt, patient.

Graphic Jump Location




Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles